These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 2600731)

  • 21. Cyclodextrin polymer, a new tablet disintegrating agent.
    Fenyvest E; Antal B; Zsadon B; Szejtli J
    Pharmazie; 1984 Jul; 39(7):473-5. PubMed ID: 6494226
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigation of curcumin-cyclodextrin inclusion complexation in aqueous solutions containing various alcoholic co-solvents and alginates using an UV-VIS titration method. Studies of curcumin and curcuminoides, XXXV.
    Hegge AB; Másson M; Kristensen S; Tønnesen HH
    Pharmazie; 2009 Jun; 64(6):382-9. PubMed ID: 19618675
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclodextrins in drug carrier systems.
    Uekama K; Otagiri M
    Crit Rev Ther Drug Carrier Syst; 1987; 3(1):1-40. PubMed ID: 3542243
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of new propofol aqueous solutions for intravenous anesthesia.
    Trapani A; Laquintana V; Lopedota A; Franco M; Latrofa A; Talani G; Sanna E; Trapani G; Liso G
    Int J Pharm; 2004 Jun; 278(1):91-8. PubMed ID: 15158952
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The pharmacokinetics and pharmacodynamics of alfaxalone in cats after single and multiple intravenous administration of Alfaxan at clinical and supraclinical doses.
    Whittem T; Pasloske KS; Heit MC; Ranasinghe MG
    J Vet Pharmacol Ther; 2008 Dec; 31(6):571-9. PubMed ID: 19000281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the anesthetic efficacy and cardiopulmonary effects of continuous rate infusions of alfaxalone-2-hydroxypropyl-beta-cyclodextrin and propofol in dogs.
    Ambros B; Duke-Novakovski T; Pasloske KS
    Am J Vet Res; 2008 Nov; 69(11):1391-8. PubMed ID: 18980420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increasing the solubility characteristics of griseofulvin with gamma-cyclodextrin.
    Kata M; Tüske B
    Pharmazie; 1988 Jan; 43(1):52-3. PubMed ID: 3375309
    [No Abstract]   [Full Text] [Related]  

  • 28. Evaluation of cyclodextrin solubilization of drugs.
    Loftsson T; Hreinsdóttir D; Másson M
    Int J Pharm; 2005 Sep; 302(1-2):18-28. PubMed ID: 16099118
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of chemically modified cyclodextrins in the development of formulations for chemical delivery systems.
    Brewster ME; Loftsson T
    Pharmazie; 2002 Feb; 57(2):94-101. PubMed ID: 11878196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The enhancement of isoflavones water solubility by complexation with modified cyclodextrins: a spectroscopic investigation with implications in the pharmaceutical analysis.
    Stancanelli R; Mazzaglia A; Tommasini S; Calabrò ML; Villari V; Guardo M; Ficarra P; Ficarra R
    J Pharm Biomed Anal; 2007 Aug; 44(4):980-4. PubMed ID: 17482414
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhancement of solubility of furosemide with beta-cyclodextrin.
    Kata M; Antal A
    Pharmazie; 1984 Dec; 39(12):856-7. PubMed ID: 6531396
    [No Abstract]   [Full Text] [Related]  

  • 32. Paclitaxel/beta-cyclodextrin complexes for hyperthermic peritoneal perfusion - formulation and stability.
    Bouquet W; Ceelen W; Fritzinger B; Pattyn P; Peeters M; Remon JP; Vervaet C
    Eur J Pharm Biopharm; 2007 Jun; 66(3):391-7. PubMed ID: 17240125
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preparation, characterization and in vivo evaluation of formulation of baicalein with hydroxypropyl-beta-cyclodextrin.
    Liu J; Qiu L; Gao J; Jin Y
    Int J Pharm; 2006 Apr; 312(1-2):137-43. PubMed ID: 16459034
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclodextrin-stabilized volatile substances for inhalation therapy.
    Gál-Füzy M; Szente L; Szejtli J; Harangi J
    Pharmazie; 1984 Aug; 39(8):558-9. PubMed ID: 6504980
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Molecular cavity filling and tabletting with beta-cyclodextrin].
    Hüttenrauch R; Fricke S
    Pharmazie; 1985 May; 40(5):361-2. PubMed ID: 4034643
    [No Abstract]   [Full Text] [Related]  

  • 36. Cyclodextrin solubilization of the antibacterial agents triclosan and triclocarban: formation of aggregates and higher-order complexes.
    Duan MS; Zhao N; Ossurardóttir IB; Thorsteinsson T; Loftsson T
    Int J Pharm; 2005 Jun; 297(1-2):213-22. PubMed ID: 15885935
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Stabilization of chlorobutanol with beta-cyclodextrin in suppositories].
    Gyulai M; Apostol I
    Acta Pharm Hung; 1986 May; 56(3):125-8. PubMed ID: 3739724
    [No Abstract]   [Full Text] [Related]  

  • 38. Production and investigating of tablets containing furosemide and beta-cyclodextrin.
    Kata M; Haragh L; Pintye-Hódi K
    Acta Pharm Hung; 1990 Jan; 60(1):40-5. PubMed ID: 2327256
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Enhancement of drug absorption with cyclodextrin inclusion complexes].
    Szejtli J; Gerlóczy A; Szente L; Bánky-Elöd E; Sebestyén G; Fónagy A; Kurcz M
    Acta Pharm Hung; 1979 Sep; 49(5):207-21. PubMed ID: 532664
    [No Abstract]   [Full Text] [Related]  

  • 40. Development of a cyclodextrin-based aqueous cyclosporin A eye drop formulations.
    Jóhannsdóttir S; Jansook P; Stefánsson E; Loftsson T
    Int J Pharm; 2015 Sep; 493(1-2):86-95. PubMed ID: 26220650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.